Lipoprotein (Lp) [a] consists of a low-density lipoprotein (LDL) like moiety bound to a highly glycosylated apolipoprotein (a) particle and an apolipoprotein B-100 particle linked via a single disulfide bond (Figure 1). Since its discovery in 1963 by Kare Berg, Lp(a) has gone relatively unnoticed in cardiovascular (CV) risk reduction algorithms (1). More recently, greater attention has been afforded to Lp(a) with growing evidence suggesting its causality in the development of atherosclerotic cardiovascular disease (ASCVD), culminating in a recent consensus statement published by the ESC (2).
Author Sub-editor: Dr Joshua Rowland Dr Joshua Rowland is a cardiology registrar working in the North West Deanery. He graduated from the University of Manchester
Author Sub-editor: Dr Atmadeep Banerjee Dr Atmadeep Banerjee is an ST4 Cardiology Registrar in the Kent, Surrey and Sussex deanery. He graduated from Calcutta National
Authors Heartbeat Sub-Editor: Sandeep Singh Dr Sandeep Singh is a Cardiology Clinical Fellow at Nottingham University Hospitals NHS Trust. After graduating from India, he completed
Authors Heartbeat Sub-Editor: Khin Kay Kay Kyaw I am currently working as cardiology specialist registrar ST6 at southwest peninsula region while also working as an